Federation des caisses Desjardins du Quebec’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
Other funds holding CAPR
SCM
TCM
VCM
RCM
JHC
Federation des caisses Desjardins du Quebec's CAPR Position: Q1 2026 in Review
Federation des caisses Desjardins du Quebec held its Capricor Therapeutics (CAPR) position steady in Q1 2026 at 856 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #2038.
Federation des caisses Desjardins du Quebec first reported a position in CAPR in Q2 2020 and has held it in 24 quarters since. The position peaked at $156K in Q1 2021. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.
- Federation des caisses Desjardins du Quebec held 856 shares of Capricor Therapeutics worth $26K as of Q1 2026.
- Federation des caisses Desjardins du Quebec left its Capricor Therapeutics share count unchanged in Q1 2026.
- Capricor Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2038 holding.
- Federation des caisses Desjardins du Quebec first reported a position in Capricor Therapeutics in Q2 2020 and has held it in 24 quarters since.
- Federation des caisses Desjardins du Quebec's Capricor Therapeutics position peaked at $156K in Q1 2021.
- 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.